DeutschNewstral
Article
The Globe and Mail on 2017-09-08 03:03
Tilray to invest $30-million in EU medical cannabis operation in Portugal
Related news
Tilray stock jumps on medical cannabis collaboration with pharma giantCBC- Cannabis producer Tilray taps private equity fundingThe Globe and Mail
Cannabis Stocks Like TILRAY are Here to Staysalem-news.com- MTilray signs first deal to supply pot to Europe out of new Portugal facilitymarketwatch.com
- MGOP congressman questions Tilray medical-cannabis imports to U.S.marketwatch.com
Aphria, Tilray combine to create biggest cannabis companySeattle Times
Cannabis producer Tilray files for IPO on Nasdaq stock exchangebusiness.financialpost.com- Tilray, Novartis strike deal to create medical marijuana lineThe Globe and Mail
- MTilray to ship 2.5 million tonnes of medical cannabis to Israelmarketwatch.com
- FTilray and the cannabis tradeft.com
[Ticker] Canadian medical cannabis firm to invest in Europeeuobserver.com- MAphria, Tilray stocks jump after report that cannabis companies are discussing mergermarketwatch.com
- MTilray stock rockets after reverse merger deal with Aphria, to create largest global cannabis companymarketwatch.com
Marijuana producers Tilray, Aphria merge to form world’s largest cannabis firmNew York Post- MTilray is well-placed to emerge a winner in the cannabis sector long term, analysts saymarketwatch.com
- MAphria and Tilray cannabis merger moves a step closer to approvalmarketwatch.com
Canadian marijuana company Tilray has first US pot IPOwbrc.com
Tilray Is No Bargain Despite Dropping $250Forbes